NeoGenomics Inc (NAS:NEO)
$ 17.74 0.56 (3.26%) Market Cap: 2.28 Bil Enterprise Value: 2.50 Bil PE Ratio: 0 PB Ratio: 2.50 GF Score: 74/100

Neogenomics Inc Annual Shareholders Meeting Transcript

May 27, 2021 / 02:00PM GMT
Release Date Price: $40.7 (+1.40%)
Operator

Good morning and welcome to the 2021 NeoGenomics, Inc. Annual Meeting of the Stockholders. I would like to introduce, Mark Mallon, CEO of NeoGenomics, Inc.

Mark W. Mallon
NeoGenomics, Inc. - CEO & Director

Thank you. Good morning and welcome to the 2021 Annual Stockholder's Meeting of NeoGenomics. I'm Mark Mallon, CEO of NeoGenomics. It is my great pleasure to welcome you here today for this meeting and to introduce Mr. Doug VanOort, our Chairman of the Board. Doug?

Douglas M. VanOort
NeoGenomics Laboratories, Inc. - Executive Chairman and CEO

Well, thank you, Mark, and welcome, everyone. We're excited to be hosting this meeting virtually, which allows us to be more inclusive and reach a greater number of stockholders.

As is customary, we will conduct the business portion of our meeting first and answer questions at the end of the meeting. Though we may not be able to answer every question, we will do our best to provide a response to as many as possible.

It is now 10:00 a.m. Eastern

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot